{"success":true,"data":{"pressRelease":{"id":"135698","rtpr_id":"nGNX17t3RT","ticker":"TDOC","exchange":"NYSE","all_tickers":["TDOC"],"title":"Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08","author":"Globe Newswire","published_at":"2026-09-03T20:35:00.100Z","article_body":"NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC),\nthe global leader in virtual care, today announced that it issued inducement\nawards to a new employee.\n\nEffective September 1, 2026, in connection with commencing employment as Chief\nFinancial Officer, Michael Grasher was granted an award of restricted stock\nunits covering 239,616 shares of Teladoc Health’s common stock, par value\n$0.001 per share (“Common Stock”), and awards of performance stock units\ncovering a target of 239,616 shares of Common Stock (for which up to 479,232\nshares may be earned). The restricted stock units vest, based on continued\nservice to Teladoc Health as to one-half of the underlying shares on the first\nanniversary of the grant date, with the remainder vesting in six substantially\nequal quarterly installments beginning on the 15-month anniversary of the\ngrant date. The performance stock units provide a target number of shares of\nCommon Stock that would be earned based on (i) Teladoc Health’s adjusted\nEBITDA for 2026 (“EBITDA PSUs”) and (ii) Teladoc Health’s actual\ncompound annual revenue growth rate during 2026-2028 (“Revenue CAGR\nPSUs”). One-half of any earned EBITDA PSUs would vest on the first\nanniversary of the grant date and the remaining one-half would vest in six\nsubstantially equal quarterly installments beginning on the 15-month\nanniversary of the grant date. Any earned Revenue CAGR PSUs would vest on\nMarch 1, 2029.\n\nThe awards were approved by the Compensation Committee of the Board of\nDirectors of Teladoc Health and were granted under the Teladoc Health, Inc.\n2023 Employment Inducement Incentive Award Plan as employment inducement\nawards pursuant to New York Stock Exchange Rule 303A.08.\n\nAbout Teladoc Health\n\nTeladoc Health (NYSE: TDOC) is the global leader in virtual care. The company\nis delivering and orchestrating care across patients, care providers,\nplatforms, and partners — transforming virtual care into a catalyst for how\nbetter health happens. Through our relationships with health plans, employers,\nproviders, health systems and consumers, we are enabling more access, driving\nbetter outcomes, extending provider capacity and lowering costs. Learn more\nat www.teladochealth.com.\n\nMedia:\nLou Serio\n202-569-9715\npr@teladochealth.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/439ced23-c1ca-477b-8607-8067a1777d11)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX17t3RT","title":"Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08","author":"Globe Newswire","ticker":"TDOC","created":"2026-09-03T20:35:00.100Z","tickers":["TDOC"],"exchange":"NYSE","article_body":"NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC),\nthe global leader in virtual care, today announced that it issued inducement\nawards to a new employee.\n\nEffective September 1, 2026, in connection with commencing employment as Chief\nFinancial Officer, Michael Grasher was granted an award of restricted stock\nunits covering 239,616 shares of Teladoc Health’s common stock, par value\n$0.001 per share (“Common Stock”), and awards of performance stock units\ncovering a target of 239,616 shares of Common Stock (for which up to 479,232\nshares may be earned). The restricted stock units vest, based on continued\nservice to Teladoc Health as to one-half of the underlying shares on the first\nanniversary of the grant date, with the remainder vesting in six substantially\nequal quarterly installments beginning on the 15-month anniversary of the\ngrant date. The performance stock units provide a target number of shares of\nCommon Stock that would be earned based on (i) Teladoc Health’s adjusted\nEBITDA for 2026 (“EBITDA PSUs”) and (ii) Teladoc Health’s actual\ncompound annual revenue growth rate during 2026-2028 (“Revenue CAGR\nPSUs”). One-half of any earned EBITDA PSUs would vest on the first\nanniversary of the grant date and the remaining one-half would vest in six\nsubstantially equal quarterly installments beginning on the 15-month\nanniversary of the grant date. Any earned Revenue CAGR PSUs would vest on\nMarch 1, 2029.\n\nThe awards were approved by the Compensation Committee of the Board of\nDirectors of Teladoc Health and were granted under the Teladoc Health, Inc.\n2023 Employment Inducement Incentive Award Plan as employment inducement\nawards pursuant to New York Stock Exchange Rule 303A.08.\n\nAbout Teladoc Health\n\nTeladoc Health (NYSE: TDOC) is the global leader in virtual care. The company\nis delivering and orchestrating care across patients, care providers,\nplatforms, and partners — transforming virtual care into a catalyst for how\nbetter health happens. Through our relationships with health plans, employers,\nproviders, health systems and consumers, we are enabling more access, driving\nbetter outcomes, extending provider capacity and lowering costs. Learn more\nat www.teladochealth.com.\n\nMedia:\nLou Serio\n202-569-9715\npr@teladochealth.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/439ced23-c1ca-477b-8607-8067a1777d11)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-09-03T20:35:00.137989803Z","server_sent_at_ms":1788467700137},"received_at":"2026-09-03T20:35:00.196Z","source_url":"https://www.globenewswire.com/news-release/2026/09/03/3356289/0/en/teladoc-health-announces-employee-inducement-awards-under-nyse-rule-303a-08.html"},"analysis":{"id":"124577","press_release_id":"135698","analysis_json":{"industry":{"label":"Health Care Providers & Services","sector":"Health Care"},"redFlags":[],"eventType":"executive_change","narrative":"Teladoc Health granted employment inducement equity awards to Michael Grasher in connection with his commencing employment as Chief Financial Officer, effective September 1, 2026.\n\nThe package consists of restricted stock units covering 239,616 shares plus performance stock units with a target of 239,616 shares that can earn up to 479,232 shares. The PSUs vest based on 2026 adjusted EBITDA and Teladoc's actual revenue CAGR over 2026-2028.\n\nThe awards were approved by the Compensation Committee and granted under the 2023 Employment Inducement Incentive Award Plan pursuant to NYSE Rule 303A.08.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine inducement-award boilerplate tied to the new CFO's start date — suppress or archive for executive-comp tracking."},"keyFigures":{"customDimensions":{"rsu_shares":239616,"psu_metrics":["2026 adjusted EBITDA","2026-2028 revenue CAGR"],"psu_max_shares":479232,"psu_target_shares":239616,"grant_effective_date":"September 1, 2026"}},"quotedText":"in connection with commencing employment as Chief\nFinancial Officer, Michael Grasher was granted an award of restricted stock\nunits covering 239,616 shares of Teladoc Health’s common stock","namedEntities":{"people":[{"name":"Michael Grasher","role":"Chief Financial Officer (commencing employment)"}],"products":[],"companies":[{"name":"Teladoc Health, Inc.","ticker":"TDOC","relationship":"filer"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"Routine inducement equity award tied to the new CFO's employment commencement; no guidance, operational, or material capital-structure change. Equity grants (~240K-720K total shares possible) are immaterial relative to Teladoc's share count."},"tickerRelevance":{"others":[],"primary":"TDOC"},"globalImportance":10,"audienceRelevance":35,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"routine-compensation-disclosure","issuerAuthored":true,"householdBrandBoost":false,"retailFavoriteBoost":"moderate — legacy COVID-era retail name"}},"event_type":"executive_change","event_type_secondary":null,"sentiment":"neutral","material_impact_score":2,"narrative":"Teladoc Health granted employment inducement equity awards to Michael Grasher in connection with his commencing employment as Chief Financial Officer, effective September 1, 2026.\n\nThe package consists of restricted stock units covering 239,616 shares plus performance stock units with a target of 239,616 shares that can earn up to 479,232 shares. The PSUs vest based on 2026 adjusted EBITDA and Teladoc's actual revenue CAGR over 2026-2028.\n\nThe awards were approved by the Compensation Committee and granted under the 2023 Employment Inducement Incentive Award Plan pursuant to NYSE Rule 303A.08.","key_figures":{"customDimensions":{"rsu_shares":239616,"psu_metrics":["2026 adjusted EBITDA","2026-2028 revenue CAGR"],"psu_max_shares":479232,"psu_target_shares":239616,"grant_effective_date":"September 1, 2026"}},"named_entities":{"people":[{"name":"Michael Grasher","role":"Chief Financial Officer (commencing employment)"}],"products":[],"companies":[{"name":"Teladoc Health, Inc.","ticker":"TDOC","relationship":"filer"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-03T21:02:18.652Z","global_importance":10,"audience_relevance":35,"importance_components":{"tickerTier":"mid-cap","eventGravity":"routine-compensation-disclosure","issuerAuthored":true,"householdBrandBoost":false,"retailFavoriteBoost":"moderate — legacy COVID-era retail name"}},"durationMs":211882,"modelName":"glm-4.7"}}